179 related articles for article (PubMed ID: 9351143)
21. Proposals to control high-cost hospital medical staffs.
Welch WP; Miller ME
Health Aff (Millwood); 1994; 13(4):42-57. PubMed ID: 7989008
[TBL] [Abstract][Full Text] [Related]
22. Cost containment in a statutory health insurance scheme by substitution of outpatient for inpatient care? The case of the Bavarian Contract.
John J; Potthoff P
Health Policy; 1987; 8(2):153-69. PubMed ID: 10312251
[TBL] [Abstract][Full Text] [Related]
23. The drug budget silo mentality: the French case.
Le Pen C
Value Health; 2003; 6 Suppl 1():S10-9. PubMed ID: 12846922
[TBL] [Abstract][Full Text] [Related]
24. Economic evaluation for pharmaceuticals in Germany.
Jönsson B
Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
[No Abstract] [Full Text] [Related]
25. [Psychopharmacological regulations. Results and commentary to the report on drug regulations 2002].
Fritze J
Nervenarzt; 2003 Mar; 74(3):301-6. PubMed ID: 12722759
[No Abstract] [Full Text] [Related]
26. Impact of the limited generalist (no hospital, no procedures) model on the viability of family practice training.
Rodney WM; Hahn RG
J Am Board Fam Pract; 2002; 15(3):191-200. PubMed ID: 12038725
[TBL] [Abstract][Full Text] [Related]
27. The diminishing presence of dermatologists in the care of hospitalized patients receiving Medicare benefits.
Kakpovbia E; Kim RH; Cohen DE; Ogbechie-Godec OA
J Am Acad Dermatol; 2020 Aug; 83(2):640-643. PubMed ID: 31682860
[No Abstract] [Full Text] [Related]
28. Insurance issues and new treatments.
Neels K
J Am Dent Assoc; 1994 Jan; 125 Suppl():45S-53S. PubMed ID: 8294675
[No Abstract] [Full Text] [Related]
29. [Significance of practice economics for the medical office].
Oberender P
Versicherungsmedizin; 2004 Mar; 56(1):1-2. PubMed ID: 15049466
[No Abstract] [Full Text] [Related]
30. [Family physicians resist high prescription risk].
Schmidt K
MMW Fortschr Med; 2003 May; 145(20):58. PubMed ID: 12822233
[No Abstract] [Full Text] [Related]
31. [After the budget limit you unfortunately consult gratis].
Walbert H
MMW Fortschr Med; 2016 May; 158(9):29. PubMed ID: 27155691
[No Abstract] [Full Text] [Related]
32. Physician volume response to price controls.
Nguyen NX
Health Policy; 1996 Feb; 35(2):189-204. PubMed ID: 10156653
[TBL] [Abstract][Full Text] [Related]
33. [EBM 2010. Starting 1 July budgets must be considered]].
Walbert H
MMW Fortschr Med; 2010 Apr; 152(17):11. PubMed ID: 20509250
[No Abstract] [Full Text] [Related]
34. [Physician adjustment to change].
Ahrens HJ
MMW Fortschr Med; 2008 Nov; 150(48):54. PubMed ID: 19127621
[No Abstract] [Full Text] [Related]
35. [Law dictates new reimbursement system. Are cost subsidy notices becoming a burden?].
MMW Fortschr Med; 2003 Sep; 145(38):56-7. PubMed ID: 14603685
[No Abstract] [Full Text] [Related]
36. The silent revolution.
Hjortdahl P
Scand J Prim Health Care; 1990 Dec; 8(4):188-90. PubMed ID: 2284516
[No Abstract] [Full Text] [Related]
37. Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting.
Fortess EE; Soumerai SB; McLaughlin TJ; Ross-Degnan D
J Am Geriatr Soc; 2001 Jun; 49(6):793-7. PubMed ID: 11454120
[TBL] [Abstract][Full Text] [Related]
38. 'Showdown in Cow Town': Texas MDs balk at contract.
Physician Relat Update; 1998 Nov; 7(11):125-6. PubMed ID: 10345020
[No Abstract] [Full Text] [Related]
39. Changes in drug utilization following the outpatient prescription drug cost-sharing program--evidence from Taiwan's elderly.
Liu SZ; Romeis JC
Health Policy; 2004 Jun; 68(3):277-87. PubMed ID: 15113639
[TBL] [Abstract][Full Text] [Related]
40. Consequences of implementing a drug budget for office-based physicians in Germany.
Schöffski O
Pharmacoeconomics; 1996; 10 Suppl 2():37-47. PubMed ID: 10163434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
